Testing exercise with acupuncture or nerve stimulation for fatigue in Sjögren's
Compares exercise alone with exercise plus acupuncture or nerve stimulation in adults with Sjögren's.
Plain-language title generated from the registry record
Registry title: Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies
Key facts
- Where
- Saint-Etienne, FranceSee the site
Where in France
- Chu de Saint EtienneSaint-Etienne, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre Hospitalier Universitaire de Saint Etienne
- Trial code
- NCT06875102
- Record updated
- 30 September 2026
- Original description
Unexplained fatigue is a frequent (60-70%) chronic complaint in Sjögren's syndrome (SjS) with a clear unmet therapeutic need, despite the recommendation of adapted physical activity (APA) programs, which are effective and feasible, but only to some extent. Hence, other therapeutic approaches, such as Acupuncture (ACU) or transcutaneous vagal nerve stimulation (tVNS), have been evaluated during the past years, with varying degrees of success in alleviating fatigue.Read full original descriptionShow less
Fatigue in Sjögren's Syndrome: a Randomized Controlled Trial of Combined Non-pharmacological Therapeutic Strategies
Unexplained fatigue is a frequent (60-70%) chronic complaint in Sjögren's syndrome (SjS) with a clear unmet therapeutic need, despite the recommendation of adapted physical activity (APA) programs, which are effective and feasible, but only to some extent. Hence, other therapeutic approaches, such as Acupuncture (ACU) or transcutaneous vagal nerve stimulation (tVNS), have been evaluated during the past years, with varying degrees of success in alleviating fatigue.
FESSONA has been designed as a randomized controlled monocentric trial, aiming at comparing the effects of 3 different programs on fatigue in SjS: APA alone, APA+ACU and APA+tVNS. Relevant controls will be included as well (sham ACU and simulated tVNS).
Multiple fatigue and SjS-related features will be measured before (at inclusion) and after (week 12) the intervention, as well as at week 24 and 48, to evaluate the short- and long-term impact of each program. Tolerance and feasibility will also be evaluated.
Inclusion: Patient affiliated or entitled to a social security scheme; Age > 18 years; Patient informed and having signed the information form and consent to participate in the study; Patient with Sjögren's syndrome according to ACR/EULAR 2016 or AECG 2002 criteria, usually followed up every year or more frequently; Fatigue present for ≥ 6 months, without obvious explanation and/or specific treatment to conduct (e.g., disease's flare, chronic infection), with a current FACIT-F score < 34.
Exclusion: Pre-existing atrial fibrillation or severe cardiac conduction disorders,; Recent stroke or myocardial infarction (<6 months),; Recurrent episodes of vasovagal syncope, or history of vagotomy; Current episode of venous or arterial thrombosis; Left ventricular ejection fraction <40% or severe heart failure (New York Heart Association functional class III or IV); People with dermatological problems in the area where the stimulation electrodes are to be placed; Pregnancy or breastfeeding; Patient under protective measures (legal protection, curatorship, guardianship); Inability or refusal to understand and/or sign informed consent to participate in the study, or to perform follow-up examinations required under the study.